1-4 of 4
Takayo Suzuki, MD, PhD
Close
Sort by
Journal Articles

A Phase II Study of THP-COP (pirarubicin, cyclophosphamide, vincristine and prednisolone) in Patients with Newly Diagnosed Advanced Peripheral T-Cell Lymphoma: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group (HMCSG)

Michinori Ogura, MD PhD, Ken Ohmachi, MD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MD PhD, Tatsuya Ito, MD, Kazuma Ohyashiki, MD, Shingo Yano, MD PhD, Michihiro Hidaka, MD PhD, Kiyoshi Ando, MD PhD, Noriko Fukuhara, MD PhD, Yoshihisa Morishita, MD PhD, Takayo Suzuki, MD PhD, Kunihiro Tsukasaki, MD PhD, Naoki Kobayashi, MD PhD, Kenji Tsukamoto, MD, Yukiyasu Ozawa, MD PhD, Tomomitsu Hotta, MD PhD, Tomohiro Kinoshita, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2789.
https://doi.org/10.1182/blood.V130.Suppl_1.2789.2789
Published: 2017
Journal Articles

Ten-Year Follow-up of Newly Diagnosed Follicular Lymphoma Patients Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) As First-Line Therapy in JCOG0203 Trial

Takashi Watanabe, MDPhD, Kensei Tobinai, MD, PhD, Masashi Wakabayashi, MSc, Yasuo Morishima, MDPhD, Hirobumi Kobayashi, MD PhD, Tomohiro Kinoshita, MD PhD, Takayo Suzuki, MD PhD, Motoko Yamaguchi, MDPhD, Kiyoshi Ando, MD PhD, Michinori Ogura, MD PhD, Masafumi Taniwaki, MD PhD, Naokuni Uike, MD, PhD, Tadashi Yoshino, MD PhD, Shigeru Nawano, MD PhD, Takashi Terauchi, MD PhD, Tomomitsu Hotta, MD PhD, Kunihiro Tsukasaki, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5168.
https://doi.org/10.1182/blood.V130.Suppl_1.5168.5168
Published: 2017
Journal Articles

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Shigeru Kusumoto, MD, PhD, Yasuhito Tanaka, MD, PhD, Ritsuro Suzuki, M.D., Takashi Watanabe, MD, PhD, Masanobu Nakata, MD, Hirotaka Takasaki, MD, Noriyasu Fukushima, MD, PhD, Takuya Fukushima, MD, PhD, Yukiyoshi Moriuchi, MD, Kuniaki Itoh, MD, PhD, Kisato Nosaka, MD, PhD, Ilseung Choi, MD, Masashi Sawa, MD, PhD, Rumiko Okamoto, MD, Hideki Tsujimura, MD, PhD, Toshiki Uchida, MD, PhD, Sachiko Suzuki, MD, PhD, Masataka Okamoto, MD, PhD, Tsutomu Takahashi, MD, PhD, Isamu Sugiura, MD, PhD, Yasushi Onishi, MD, PhD, Mika Kohri, MD, PhD, Shinichiro Yoshida, MD, PhD, Rika Sakai, MD, Minoru Kojima, MD, PhD, Hiroyuki Takahashi, MD, PhD, Akihiro Tomita, MD, PhD, Dai Maruyama, MD, PhD, Yoshiko Atsuta, MD, PhD, Eiji Tanaka, MD, PhD, Takayo Suzuki, MD, PhD, Tomohiro Kinoshita, M.D., Ph.D., Michinori Ogura, MD, PhD, Masashi Mizokami, MD, PhD, Ryuzo Ueda, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2641.
https://doi.org/10.1182/blood.V120.21.2641.2641
Published: 2012
Journal Articles

Phase II/III Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab (R-CHOP) Versus Biweekly CHOP with Rituximab (R-Bi-CHOP) In Untreated Advanced-Stage Indolent B-Cell Lymphoma: Japan Clinical Oncology Group (JCOG) 0203 Trial

Takashi Watanabe, MD, PhD, Yasuo Morishima, MD, PhD, Taro Shibata, MSc, Nobuo Maseki, MD, PhD, Tomohiro Kinoshita, MD, PhD, Takayo Suzuki, MD, PhD, Motoko Yamaguchi, MD, PhD, Kiyoshi Ando, MD, PhD, Michinori Ogura, MD, PhD, Masafumi Taniwaki, MD, PhD, Naokuni Uike, MD, PhD, Kengo Takeuchi, MD, PhD, Shigeru Nawano, MD, PhD, Takashi Terauchi, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Tomomitsu Hotta, MD, PhD, Kensei Tobinai, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 431.
https://doi.org/10.1182/blood.V116.21.431.431
Published: 2010